You feel the shift before any lab confirms it: recovery drags, sleep fragments, and the weights that used to move smoothly now demand more from you. Before writing that off as "just your age," it is worth understanding the objective, trendable measures that separate a normal training week from a real change in physiology.
Why a single lab snapshot misleads
As a clinician you already know the trap: one estradiol draw on one morning tells you almost nothing about a perimenopausal woman whose hormones swing week to week. The Study of Women's Health Across the Nation (SWAN) documented that the menopause transition is characterized by highly variable, non-linear hormonal patterns rather than a clean downslope [1]. That variability is exactly why function-and-composition metrics, trended over time, often tell a more honest story than any one-time hormone value.
Two of the most durable of those metrics are grip strength and appendicular lean mass. Both are cheap or moderately priced to measure, both are reproducible, and both have been studied as markers that track with broader health rather than vanity.
Grip strength: a small measurement with outsized signal
Grip strength is measured with a hand dynamometer in a standardized position, and it functions as a proxy for total-body strength and neuromuscular integrity. In a large international prospective cohort (PURE, roughly 140,000 adults across 17 countries), lower grip strength was associated with higher all-cause mortality and cardiovascular events, and the authors described it as a stronger predictor of death than systolic blood pressure in their analysis [2]. That does not mean a low reading dooms anyone; it means grip is a legitimate vital sign of function that deserves to be tracked, not dismissed.
For a woman who has trained for decades, the value is not a single reading against a population norm. It is *your* number, taken the same way, a few times a year. A quiet, sustained downward trend that coincides with longer recovery and fragmented sleep is a data point worth bringing to a provider, not something to explain away.
Appendicular lean mass and what DEXA actually tells you
Appendicular lean mass (ALM) is the lean soft tissue in your arms and legs, most precisely quantified by dual-energy X-ray absorptiometry (DEXA). Clinicians commonly normalize it to height (ALM divided by height squared) to create an index used in screening for low muscle mass. The European Working Group on Sarcopenia in Older People (EWGSOP2) put forward reference cut points, including an ALM index threshold near 5.5 kg/m² in women, as part of a framework that pairs muscle *quantity* with muscle *strength and function* [3]. In other words, the consensus itself treats a composition number as incomplete without a function number beside it, which is precisely the point for a midlife woman refusing to guess.
DEXA also reports total lean mass, fat mass, and regional distribution, and repeated scans reveal direction of travel. A stable or rising ALM alongside preserved grip suggests your strength-preservation work is holding. A drifting ALM, especially with rising visceral or trunk fat, is the kind of signal that reframes "I'm just getting older" into "something measurable is changing, and here are the levers."
Bone density belongs in the same conversation
The estrogen decline of the menopause transition accelerates bone loss, and DEXA is the same tool that quantifies bone mineral density (BMD). The World Health Organization T-score framework defines osteopenia as a T-score between -1.0 and -2.5 and osteoporosis at -2.5 or below [4]. Because one DEXA appointment can capture body composition and bone density together, it is an efficient anchor for a woman who wants the full structural picture rather than a fragment of it.
T-score · marker = Osteopenia threshold
The hormonal and recovery picture, measured honestly
Longer recovery and fragmented sleep are not automatically "in your head," and they are not automatically hormonal either. A thorough workup trends more than one thing: thyroid function, iron and ferritin, vitamin D, fasting glucose and an HbA1c, a lipid panel, and, in the right clinical context, sex hormones interpreted against cycle timing and symptoms rather than a lone value. The North American Menopause Society (now The Menopause Society) position statements emphasize individualized, symptom-and-risk-based evaluation over reflexive dismissal, and they are a credible reference point for what a serious perimenopause assessment looks like [5].
This is the part your PCP may have skipped. Being told "that's normal" is not the same as being *evaluated*. The goal of a good longevity workup is not to pathologize aging; it is to establish your personal baselines and watch the trend lines so that decisions rest on data.
Source: [3] Sarcopenia: revised European consensus on definition and diagnosis (EWGSOP2), Age and Ageing, [4] WHO criteria and bone mineral density T-score classification (NIH Osteoporosis and Related Bone Diseases Resource)
From metrics to a strength-preservation plan
Once you have baselines, the levers are unglamorous and well supported. Progressive resistance training is repeatedly associated with preserved muscle strength and function across adult populations, and physical-activity guidance from the U.S. Department of Health and Human Services recommends muscle-strengthening activities on two or more days per week for adults [6]. Adequate protein intake, sleep, and management of the metabolic markers above round out the foundation. None of this is exotic, and that is the point: the metrics tell you whether the fundamentals are working *for you*, specifically.
Where hormonal therapy or other interventions enter the picture, that is a conversation for a licensed provider who has your labs, your history, and your goals in front of them. Some longevity clinics discuss compounded medications, including compounded peptides or hormones. If that comes up, understand the regulatory context clearly. Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state. A prescription is never guaranteed; whether any medication is appropriate is decided by an independent, licensed provider.
This article is educational and is not medical advice, diagnosis, or a recommendation to take any specific medication.
Where Velri fits
Velri is a technology and coordination company, not a medical practice. Velri does not provide medical care and employs no physicians. What Velri can do is coordinate the logistics that make trending your metrics practical: helping arrange lab work, connecting you with an independent, physician-led Provider Group for a visit where your results and goals are reviewed, and, if a provider determines it is appropriate and writes a prescription, coordinating with an independent, licensed pharmacy to fulfill it. Care and prescribing decisions belong entirely to the independent providers. Coverage currently starts in Nevada, with more states rolling out over time. The aim is simple: give an informed woman the baselines and the partnership to make decisions from data, not from assumptions about her age.
